Gliatech other research news

The Cleveland company received an $80,000 SBIR grant from the National Institute of Aging to identifying agents that can stop the progression of Alzheimer's disease.

The research draws on parallels being made between the disease and chronic inflammation. In a small study of Alzheimer's patients, cognitive decline in some cases appears to have been slowed by treatment with classical anti-inflammatory drugs. ...